23 May 2013
Keywords: benitec, licensee, tarcere, signs, asian, tt-033, deal
Article | 24 March 2008
Australian biotechnology company Benitec says that its US licensee Tarcere Therapeutics and Japan's Oncolys BioPharma are to collaborate
on a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 March 2008
22 May 2013
© 2013 thepharmaletter.com